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Background: Studies carried out on specific travelers’ groups such as students describe an increase in the
consumption of alcohol and drugs during travel and vacation time. The present study investigates the risk
behaviors (alcohol and drugs) in a general adult population in Switzerland travelling abroad who visited a travel
clinic before departure.
Methods: This retrospective study was conducted in a travel clinic between January 2006 and December 2008.
14,496 patients came to the clinic for a pre-travel consultation. 3,537 of them answered a questionnaire about their
life habits in Switzerland and during their last trip. The only exclusion criterion was an age inferior to 18 years old.
The consumption habits of drugs and at-risk alcohol intake (8 standard drinks (SD) per week for women and 15 SD
for men) was analyzed according to gender, sex, destination and profession. Predictors of adopting a risky behavior
between habits in Switzerland and during their previous trip were also analyzed.
Results: 7% (229/3477) of participants declared having at-risk alcohol consumption in Switzerland and 14% (473/
3275 [95% CI 13–16]) during their trip. 9% (332/3527) of the participants used drugs in Switzerland and 5% (178/
3481) during their trip. Risk factors for at-risk alcohol consumption during a trip were: at-risk alcohol consumption
in Switzerland (OR 31[95% CI 21–45]), smoking (1.7 [95% CI 1–2]), use of drugs in Switzerland (OR 2.2 [95% CI 2–3]),
leisure travel (OR 1.6 [95% CI 1–2]) and managerial professions (OR 1.8 [95% CI 1–3]). Risk factors for the use of drugs
during a trip were: alcohol consumption in Switzerland (OR 2.1 [95% CI 1–4]), smoking (OR 1.9 [95% CI 1–3]), and
use of drugs in Switzerland (OR 29.7 [95% CI 19–45]).
Conclusions: At-risk alcohol consumption and, to a lesser extent, use of drugs, affect a large number of travelers
which expose them to health problems during a trip. Exploring the alcohol and drugs consumption patterns of
people visiting a travel clinic should be part of the pre-travel routine consultation and would allow to identifying
people who would benefit most from a specific prevention.
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Swiss citizens took 10,5 million trips abroad in 2009,
mostly in Europe. About 10% of the departures had an
extra-European destination [1]. There are no specific rec-
ommendations or counseling during pre-travel consulta-
tions about the risks linked to the consumption of alcohol
and drugs during a trip, whereas prevention against infec-
tious diseases, road hazards or sun exposure is common
[2]. Yet studies carried out on young students and trav-
elers have demonstrated an increase in the consumption* Correspondence: nicolas.senn@hopsvd.ch
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article, unless otherwise stated.of alcohol and drugs during travel and vacation time [3-6].
Such behaviors can have significant health implications
and can notably lead to road traffic accidents [7] and the
appearance or aggravation of psychiatric disorders (de-
pressive state, panic disorder, anxiety disorder, psychosis)
[8]. Some behaviors can also increase the risk of arrests
and detentions [9]. Moreover, a review of several studies
carried out on young people under the age of twenty has
shown that the consumption of alcohol was linked to an
increase in unprotected casual sex and multiple or occa-
sional sexual relationships [10,11], which multiply the risk
of contracting a sexually transmitted infection (STI).Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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consumption are well known in Switzerland. In 2007,
15% of the population of age 15 and above abstained
from drinking alcohol, 26% drank less than once a week,
44% drank every week but not every day and 14% drank
on a daily basis. Women were twice more abstinent than
men (21% versus 10%). The proportion of persons who
drank on a daily basis increased up to the 65–74 years
old group before stabilizing. The proportion of persons
who had a “binge drinking” episode (more than 4 drinks
per occasion for men and 3 for women) at least once a
month reached its peak in the 15–24 years old group
(21%) before decreasing linearly with age (2% in the
group of 75 years old and above) [12]. The consumption
of drugs is more frequent among young people and
men, with cannabis being the most consumed drug,
followed by cocaine and ecstasy [13]. According to the
Swiss Health Survey of 2007, 22% of persons under 70
years old had smoked cannabis at least once in their
lives, mostly among young people: 45% of men and 26%
of women between 25 and 34 years old. In Switzerland,
4% of men versus 2% of women older than 15 years had
used cocaine once and 2% of men versus 1% of women
had tried ecstasy [14].
The information on at-risk alcohol consumption and
use of drugs during travel time were derived from studies
that were carried out only in specific populations or spe-
cific destinations. A recent prospective study conducted
on British college students describes an increase in the
number of consumers (RR=1.59) and in the frequency of
alcohol consumption, as well as in the number of cannabis
consumers (RR= 1.35) during the summer break [3].
Among young backpackers (18–35 years old) on a long
duration trip in Australia, more than a quarter consumed
alcohol and cannabis more frequently (while there was a
decrease of the consumption of other drugs) [4]. In tourist
resorts with significant nightlife activities, the total num-
ber of travelers who consume drugs diminishes (except for
ecstasy), but those who routinely use drugs increase their
consumption [5]. To our knowledge, no study has been
carried out in a general population. It remains unknown
to what extent such behaviors change between home and
during a trip, nor which factors could predict a change of
behavior. This is the aim of this study, which investigates
risk behaviors (alcohol and drugs) in an adult population
in Switzerland and travelling abroad who consulted a
travel clinic before departure. Improving the knowledge
on these specific risky behaviors may help to better target
the recommendations given to travelers.
Methods
Population and setting
This study was conducted at the Travel Clinic of the De-
partment of Ambulatory Care and Community Medicine ofthe University of Lausanne between January 2006 and De-
cember 2008. The objective was to explore through a self-
administered questionnaire the life habits in Switzerland
and during the last trip abroad of people visiting the Clinic.
These data have been collected along a randomized clinical
trial (RCT), which evaluated the impact of a brief inter-
vention (BI) on the prevention of unprotected casual sex
during travel. The method and results of this trial have
been published in BMC infectious diseases [15]. But in
brief, among all travelers filling the self-administered ques-
tionnaire, 1681 patients aged 18–44 years old planning to
travel alone were randomly allocated to one of the three
arms: 1) BI + provision of a box of condoms; 2) provision
of a box of condoms alone and 3) usual care. The two in-
terventions were provided by trained staff of the travel
clinic. A post-travel questionnaire was also filled by these
patients in order to assess the efficacy of the interventions
by measuring the rate of unprotected casual sex inter-
courses during the trip.
Patients of the travel clinic are seen by nurses or physi-
cians under the supervision of travel medicine specialists.
A standard consultation lasts from 15 to 25 minutes.
About 7,000 travelers are seen yearly at the Clinic on one
or more occasions.
Data collection
Between January 2006 and December 2008, 14,496 eligible
travelers visited the Clinic for a pre-travel consultation.
Among them, 3,537 participants were recruited by the ad-
ministrative staff in the waiting room. The only exclusion
criterion was an age inferior to 18 years old. The limited
number of administrative personnel explains the low rate
of participants in comparison with the total number of cli-
ents. All the participants filled in a self-administered ques-
tionnaire in the waiting room. It concerned their life
habits in Switzerland and during their previous trip (last
trip out of Switzerland). The questions related to demo-
graphic characteristics (gender, origin, marital status, oc-
cupation), their sexual habits (sexual orientation, spouse,
occasional partner(s), protection during occasional sexual
intercourse), their risk behaviors in Switzerland and
abroad (consumption of alcohol, use of drugs and unpro-
tected casual sex with an occasional partner), and the pur-
pose of their last trip (vacation-leisure, business trip).
Study design and procedure
This is an observational study using retrospective data,
whose goal is to describe the risk behaviors of adults in
Switzerland and during their last trip abroad: at-risk alco-
hol consumption and use of drugs. At-risk alcohol con-
sumption has been defined as being superior or equivalent
to 8 standard drinks (SD) per week for women and 15
SD for men. This conservative definition is broadly used
not only in Switzerland [16] but also internationally. It is
14’496 
Clients visiting the travel clinic
3537 
Travelers > 18 years  filled a 
questionnaire on their life habits in 
Switzerland and during their previous 
trip
1681 travelers aged 18 – 44 years 
included in a randomized controlled trial 
for the prevention of sexual transmitted 
infections (results not presented here)
10.959 
Excluded persons (refused 
participation, have 
excluding criteria, omitted)
Figure 1 Study flow-chart.
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Abuse and Alcoholism in the United States and taken as
reference in many scientific publications [17]. These low
thresholds were also used because we were mostly inter-
ested in investigating changes of habits between home and
travel rather exploring absolute consumption. Therefore
lower thresholds were more likely to capture changes of
behaviors. With regard to drugs, we considered that any
consumption was at-risk, regardless of the substance or
the quantity (cannabis, ecstasy, cocaine, LSD, NMDA, her-
oin, speed, hallucinogenic mushrooms).
The risk behaviors were analyzed according to the
following variables: 1) age category (<25 years old, 25–35
years old, 36–45 years old and >45 years old); 2) gender;
3) occupation, divided in 5 groups depending on the
socioeconomic status (A: academic and intellectual profes-
sions, B: managers and universities of applied sciences
(HES), C: Federal Certificate of Proficiency (CFC) and
employees, D: retired and unemployed persons and
E: students) in accordance with the International Stand-
ard Classification of Occupations from the International
Labor Organization (ISCO-88); 4) countries of destination
classified by regions of the world according to the United
Nations (Africa [AF], America [AM], Asia [AS] and
Europe [EU]; Oceania [OC] and multiple destinations
[MD] were not taken into account given the low number
of travelers) [18,19] and 5) type of travel (vacation-leisure
[visiting family or friends] vs. business trip). The predictive
factors of a change of behavior were also investigated
(new risk behavior during the trip in comparison with
behavior at home).
The study was approved by the ethics committee of
the University of Lausanne in September 2005 and regis-
tered (ClinicalTrials.gov: NCT01056536).
Data analysis
The data were entered in Access software (Microsoft Office
2003) and the statistical analyses were performed on Epi
Info 3.5.3. and STATA 12.0. A chi2 test was used to investi-
gate the difference observed between two proportions
(p < 0.05). A bivariate analysis was performed to calculate
odds ratios (OR) and to identify the predictive factors of
risk behavior during a trip and of a change of behavior dur-
ing a trip with a confidence interval of 95%. The predictive
factors with an OR where the confidence interval did not
include 1 in the bivariate analysis were taken into account
and entered into an analysis for the purpose of building a
multivariate logistic regression model in order to calculate
the OR adjusted to the predictive factors of the cohort.
Results
Description of the cohort
Among the 14,496 eligible travelers who visited the
travel clinic during the study, 3,537 filled in the firstquestionnaire. 1,681 persons took part in the random-
ized study on the BI and completed the second ques-
tionnaire when they came back from their trip. Figure 1
displays the study flowchart.
Table 1 summarizes the general characteristics of all the
participants among whom 72 % were Swiss, 17% came
from Europe (outside of Switzerland), 4% from Africa, 3%
from America and 1% from Asia.
Prevalence rates of risk behaviors in Switzerland vs.
during the previous trip
In Switzerland, 56% (1980/3529 [95% IC 55–58] of the
participants drank alcohol, their average consumption be-
ing 6.1 SD per week. During the trip, 67% (2327/3481
[95% IC 65–68]) of the participants drank alcohol and
their average consumption was 8.1 SD per week (p < 0.01).
At-risk alcohol consumption in Switzerland was reported
by 7% (229/3477 [95% IC 6–8]) of the participants. During
the trip, 14% (473/3275 [95% IC 13–16]) of the partici-
pants had at-risk consumption (p < 0.01).
Nine percent (332/3527 [95% IC 9–10]) of the partici-
pants used drugs in Switzerland and 5% (178/3481 [95%
CI 4–6]) while travelling. Cannabis was the most con-
sumed drug in both cases: 86% (285/332) in Switzerland
and 87% (154/178) during the trip. The other drugs
consumed in Switzerland were: cocaine (N = 23), ecstasy
(N = 18), LSD (N = 7), MDMA (N = 5), heroin (N = 2),
speed (N = 2) and hallucinogenic mushrooms (N = 1).
Figure 2 displays the prevalence rates in Switzerland and
abroad of at-risk alcohol consumption (2a) and drugs
use (2b) stratified by age categories.
Risk behaviors according to gender in Switzerland and
during a trip
In Switzerland, 49% (864/1770 [95% CI 47–51]) of women
drank alcohol and their average consumption corresponded
to 4.9 SD per week. As far as men were concerned, 64%
(1111/1749 [95% CI 61–66]) of them drank alcohol with an
Table 1 General characteristics of the participants
Characteristics Percent (%) 95% IC
N 3537
Female 1771 50 48-52
Mean age (years) 34
Nationality Swiss 2557 72 71-74
Destination previous trip
Africa 558 16 15-17
America 649 18 17-20
Asia 582 16 15-18
Europe 1524 43 41-45
Oceania 64 2 1-2
Multiple destinations 27 1 1
Others 133 4 3-4
Main reason for trip
Leisure 3056 86 85-88
Professional 393 11 10-12
Unknown 88 3 2-3
Professional categories
A (academics and intellectuals) 730 21 20-23
B (managers) 1018 30 28-31
C (employees) 858 25 24-26
D (retired and unemployed) 147 4 4-5
E (students) 686 20 19-21
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17% (144/840 [95% CI 15–20]) of women who drank had
at-risk consumption compared to 8% of men who drank
(85/1084 [95% CI 6–10]). During a trip, 61% (1058/1744
[95% CI 58–63]) of women drank alcohol and their average
consumption corresponded to 6.4 SD per week, whereas
73% (1263/1727 [95% CI 71–75]) of men drank alcohol
with an average consumption of 9.6 SD per week. Figure 3
shows the prevalence rates of at-risk alcohol consumption
(3a) and drug use (3b) stratified by gender.
Risk behaviors according to destination and purpose of
trip
Nineteen percents (268/1436 [95% CI 17–21]) of the
participants had at-risk alcohol consumption during a
trip in Europe, 13% (77/604 [95% CI 10–16]) in Amer-
ica, 10% (53/518 [95% CI 8–13]) in Africa and 11% (61/
554 [95% CI 9–14]) in Asia. Six percents (83/1522 [95% CI
4–7]) of the participants consumed drugs in Europe, 6%
(39/647 [95% CI: 4–8]) in America, 5% (25/558 [95% CI:
3–7]) in Africa and 3% (18/579 [95% CI: 2–5]) in Asia.
During a vacation-leisure trip (VL), 15% (428/2865
[95% CI 14–16]) of the participants had at-risk alcohol
consumption and 11% (41/371 [95% CI 8–15]) during a
business trip (BT).During a VL, 5% (162/3046 [95% CI 5–6]) of the partici-
pants used drugs and 4% (15/393 [95% CI 2–6]) during
a VP.
Predictors of risk behaviors during a trip
Table 2 presents odds ratios (OR) of potential risk fac-
tors for travelers who engaged in a risk behavior (at risk
alcohol consumption or drugs use) during their last trip
(N = 3537) in bivariate analysis.
In multivariate analysis, the following predictors were
associated with a risk behavior during a trip. With re-
gard to at-risk alcohol consumption during a trip: at-risk
alcohol consumption in Switzerland (OR 30,8 [95% CI
21–45]), smoking (OR 1.7 [95% CI 1–2]), use of drugs in
Switzerland (OR 2.2 [95% CI 2–3]), leisure travel (OR
1.6 [95% CI 1–2]) and professional category of managers
(OR 1.8 [95% CI 1–3]). With regard to use of drugs dur-
ing the trip: consumption of alcohol in Switzerland (OR
2.1 [95% CI 1–4]), smoking (OR 1.9 [95% CI 1–3]) and
use of drugs in Switzerland (OR 29.7 [95% CI 19–45]).
Predictors of a change of behavior (switching to a risk
behavior during a trip)
The total number of people who engaged in a new risk
behavior during their vacation corresponds to 298/473
(63%) with regard to alcohol and to 44/178 (25%) with
regard to drugs. Table 3 presents the predictors of a
change of behavior during a trip.
The adjusted OR for predictors for a change of behavior
during a trip, with regard to at-risk alcohol consumption,
were: smoking (OR 1.5 [95% CI 1–2]), use of drugs in
Switzerland (OR 2.2 [95% CI 2–3]), leisure travel (OR 1.7
[95% CI 1–3]) and the professional category of managers
(OR 2 [95% CI 1–3]); with regard to drugs: consumption
of alcohol in Switzerland (OR 3.4 [95% CI 2–8]).
Discussion
This study explores the consumption of alcohol and
drugs of clients of a travel clinic during their trip abroad
in comparison to their habits in Switzerland. It shows
that at-risk alcohol consumption and use of drugs was a
problem that travelers often encounter. Overall at-risk
alcohol consumption increased during a trip (from 7%
to 14%), while the use of drugs appears to decrease dur-
ing a trip (from 9% to 5%).
The increase of at-risk alcohol consumption affected
all of the participants. It was however stronger among
young people under 35 years old (from 5% to 15%),
while older people had a higher at-risk alcohol con-
sumption at home (11%), which increased less sharply
during a trip (15%). This may be explained by different
habits of consumption: binge drinking is more frequent
among young people, while a chronic excessive con-
sumption mostly affects people above 55 years old [12].
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Figure 2 At-risk consumption of alcohol (a) and use of drugs (b) in Switzerland and during their last trip by group of age (prevalence
in percent).
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at-risk alcohol consumption at home (8% versus 5%) and
during a trip (16% versus 13%), unlike the report of the
Swiss Health Survey of 2007, which showed that punc-
tual inebriations (more than 5 SD/occasion) and chronic
excessive consumption (more than 4 SD/day) were more
prevalent among men. The definitions of at-risk alcohol
consumption [16] used in our study establish different
thresholds for men and women, which partly explains
these results (the absolute average consumption being
lower for women: 4.9 SD/week versus 7.1 SD/week for
men in Switzerland). The prevalence of at-risk alcohol
consumption was significantly stronger in the case of
European destinations, which is most likely linked to local
habits: the consumption of alcohol in Europe is also
higher in comparison with other regions of the world, ac-
cording to the last Global status report on alcohol and
health published by the World Health Organization(WHO) [20]. In addition, it may be that it is more difficult
to get alcohol outside of Europe, in particular in predom-
inantly Muslim countries.
The consumption of drugs decreased significantly dur-
ing a trip, dropping from 9% to 5% of all the participants,
and only 1% had a new consumption of drugs while travel-
ling. This decline applied to all of the participants regard-
less of their age or gender. This may be explained by the
fact that despite the worldwide production and consump-
tion of cannabis, [21] many countries have introduced very
restrictive regulation which has reduced its availability.
The decrease of drugs consumption during a trip is in
contradiction with the results of previous studies. It may
be explained by the fact that this study pertains to a gen-
eral population of travelers who are more concerned about
their health since they consult a Travel Clinic before a trip
and, consequently, might reduce their consumption of
drugs during a trip. Moreover, persons who travel to
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Figure 3 At-risk alcohol consumption (a) and drug use (b) by gender (prevalence in percent).
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sumption of drugs than the average, which may explain
the decrease of drugs consumption during a trip to other
regions of the world. There is most likely a problem of ac-
cessibility in certain countries (travelers are less familiarTable 2 Predictors of risk behavior during a trip
Drug consum
Characteristics N Drug
Women 1747 67 (4%)
<36 years old 2235 153 (7%)
Smoker 975 123 (13%)
Drug use in Switzerland 322 133 (41%)
At-risk alcohol consumption in Switzerland 227 30 (13%)
Without stable partner 1051 72 (7%)
Type of travel
Business trip 393 15 (4%)
Vacation-leisure 3046 162 (5%)
Professional category
A (academics and intellectuals) N/A N/A
B (managers and HES) 1010 46 (5%)
C (employees and CFC) 836 48 (6%)
D (retired and unemployed) 143 3 (2%)
E (students) 672 54 (8%)with the market than in their own country). Furthermore,
fear of foreign laws, which may be severe with regard to
drugs, is likely to be an impediment to consumption [22].
Pre-travel consultation is the ideal moment to address
the aspects of travel-related hazards and the consumptionption At-risk alcohol consumption
OR (95% CI) N Alcohol OR (95% CI)
0.6 (0.4-0.8) 1664 264 (16%) 1.3 (1-1.5)
3.9 (2.5-6.3) 2105 317 (15%) 1.1 (1-1.4)
6.4 (4.6-8.9) 908 216 (24%) 2.6 (2.1-3.1)
50 (34.3-72) 297 94 (32%) 3.2 (2.4-4.1)
3.2 (2-4.9) 216 169 (78%) 33 (23.3-46.5)
1.6 (1.2-2.2) 988 166 (17%) 1.3 (1.1-1.6)
0.7 (0.4-1.2) 371 41 (11%) 0.7 (0.5-1)
1.4 (0.8-2.4) 2866 429 (15%) 1.4 (1-2)
Ref. N/A N/A Ref.
1.5 (0.9-2.4) 955 163 (17%) 1.6 (1.2-2.2)
1.9 (1.1-3.1) 780 105 (13%) 1.2 (0.9-1.7)
0.7 (0.2-2.2) 130 19 (15%) 1.4 (0.8-2.3)
2.7 (1.6-4.4) 634 94 (15%) 1.4 (1-1.9)
Table 3 Predictors of a change of behavior during a trip
Drug consumption At-risk alcohol consumption
Characteristics N Drug OR (95% CI) N Alcohol OR (95% CI)
Women 1752 21 (1%) 0.9 (0.5-1.7) 1669 155 (9%) 1.1 (0.8-1.3)
<36 years old 2242 39 (2%) 4 (1.6-10.3) 2113 219 (10%) 1.6 (1.2-2.1)
Smoker 984 19 (2%) 2 (1.1-3.6) 917 124 (14%) 2 (1.6-2.5)
Drug use in Switzerland N/A N/A N/A 300 59 (20%) 2.8 (2.1-3.9)
At-risk alcohol consumption in Switzerland 229 8 (4%) 3.2 (1.5-6.9) N/A N/A N/A
Without partner 2428 25 (1%) 0.6 (0.3-1) 2287 198 (9%) 0.8 (0.7-1.1)
Type of travel
Business trip N/A Ref. N/A N/A Ref. N/A
Vacation-leisure 3048 43 (1%) 5.6 (0.8-40.8) 2873 274 (10%) 1.8 (1.1-2.8)
Professional catagory
A (academics and intellectuals) N/A Ref. N/A N/A Ref. N/A
B (managers and HES) 1012 10 (1%) 1 (0.4-2.7) 958 119 (12%) 2.2 (1.5-3.2)
C (employees and CFC) 841 7 (1%) 0.9 (0.3-2.5) 784 58 (7%) 1.2 (0.8-1.9)
D (retired and unemployed) 143 1 (1%) 0.7 (0.1-6) 130 8 (6%) 1 (0.5-2.2)
E (Students) 672 18 (3%) 2.8 (1.2-6.8) 637 66 (10%) 1.8 (1.2-2.7)
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lence of these risky behaviors. It is however often difficult
to address all aspects of travel prevention, as the major
part of the consultation is often dedicated to infectious
diseases (malaria, diarrhea, etc.). In this context, it is useful
to know the predictors of a risk behavior in terms of alco-
hol and drugs use in order to better target the prevention
messages to travelers who need them.
In our study, we observed that people who had an ex-
cessive consumption of alcohol or who used drugs in
Switzerland will continue this behavior during their trip.
We also observed that smoking, travelling for leisure
and the professional category of managers were also sig-
nificant risk factors. Moreover, the persons who engaged
in a new risk behavior during a trip by increasing their
consumption of alcohol or by using drugs for the first
time will put themselves in particular danger. In our
study, smoking, use of drugs, travelling for leisure and
being in a managerial position are predictors of a change
of behavior with regard to the consumption of alcohol.
Being aware of these factors can be useful in routine
practice and simply asking the travelers about their
consumption of alcohol and drugs would allow for the
identification of those who would benefit most from
receiving specific preventive advice. These aspects of
prevention are an integral part of primary care consulta-
tions, but are rarely addressed during pre-travel counsel-
ing. In this respect, it is interesting to notice that the last
American recommendations in travel medicine only
mention alcohol as a cause of road traffic accidents [2].
Finally, we also noticed that, despite widespread misper-
ceptions, young age and being a student are not linkedto a risk behavior with regard to the consumption of al-
cohol during a trip.
Among the limitations of this study, first it is likely
the participants are concerned about their health since
they consulted a Travel Clinic and therefore represent a
lower-risk profile than the general population. Second, the
measure of the consumption of alcohol and drugs was
performed retrospectively (after the last trip), a recall bias
might therefore underestimate the true prevalence rates.
However, we estimated prospectively, along the random-
ized controlled trial on the prevention of STI, [15] the
prevalence rates of drugs and at-risk alcohol consumption
in a subgroup of travelers (Klunge et al. unpublished data)
who filled a post-travel questionnaire and found out the
following prevalence rates: 18% for excessive consumption
of alcohol (versus 14% during the last trip) and 7% for
drugs (versus 5%). These numbers, while slightly higher in
comparison with those obtained retrospectively in this
study (which was expected due to recall bias) confirm the
importance of the risks taken during a trip by travelers.
One of the strengths of this study is the significant size of
the sample, which allows a sufficient power to analyze the
predictors of a change of behavior. Another factor that
might have modified the true prevalence rates is the fact
that it was a self-administered questionnaire. The col-
lected data relied therefore entirely on the willingness to
answer of the travelers.
Another limitation is that the questionnaire did not
record binge drinking behavior. It would have been in-
deed interesting to have this additional information as it
is now a well recognized public health problem affecting
different groups of populations. One reason explaining
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was created in 2005, binge drinking was less of a recog-
nized problem than now. However, with the low thresh-
olds used in this study (8 SD for women and 15SD for
men) it is likely that we have caught most problematic
alcohol consumers.
Finally, the data were collected six years ago, raising
the question of knowing if it is timely enough to provide
accurate conclusions. We believe however, that it is un-
likely that drugs and alcohol consumption’s habits have
sufficiently changed over these six years to significantly
affect the results.
Conclusions
At-risk alcohol consumption and, to a lesser extent, use
of drugs, affect a large number of travelers, regardless of
gender or age. Investigating the habits of alcohol and
drug consumption of travelers should be an integral part
of the pre-travel routine consultation and would allow
for the identification of the people who would benefit
most from a specific prevention. However, it remains to
be determined which interventions are best suited to
prevent such risk-taking during a trip. More generally,
prevention messages regarding the risks associated with
excessive consumption of alcohol and use of drugs dur-
ing a trip should be more widely disseminated in travel
clinics.
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